Background:: At high medicinal doses perchlorate is known to decrease the production of thyroid hormone, a critical factor for fetal development. In a large and uniquely exposed cohort of pregnant women, we recently identified associations between environmental perchlorate exposures and decreased maternal thyroid hormone during pregnancy. Here, we investigate whether perchlorate might be associated with birthweight or preterm birth in the offspring of these women. Methods:: Maternal urinary perchlorate, serum thyroid hormone concentrations, birthweight, gestational age, and urinary nitrate, thiocyanate, and iodide were collected in 1957 mother-infant pairs from San Diego County during 2000-2003, a period when the county's water supply was contaminated with perchlorate. Associations between perchlorate exposure and birth outcomes were examined using linear and logistic regression analyses adjusted for maternal age, weight, race/ethnicity, and other factors. Results:: Perchlorate was not associated with birth outcomes in the overall population. However, in analyses confined to male infants, log 10 maternal perchlorate concentrations were associated with increasing birthweight (β=143.1 gm, p=0.01), especially among preterm births (β=829.1 g, p < 0.001). Perchlorate was associated with male preterm births ≥2500 g (odds ratio=3.03, 95% confidence interval=1.09-8.40, p-trend=0.03). Similar associations were not seen in females. Conclusions:: This is the first study to identify associations between perchlorate and increasing birthweight. Further research is needed to explore the differences we identified related to infant sex, preterm birth, and other factors. Given that perchlorate exposure is ubiquitous, and that long-term impacts can follow altered birth outcomes, future research on perchlorate could have widespread public health importance.
Introduction
Perchlorate (ClO 4 -) is a highly stable oxidizing chemical component of missile fuel, road flares, and other products. Perchlorate exposure in the US is ubiquitous, typically occurring through contaminated food or water. In a recent nationwide US survey, perchlorate was detected in the urine of every person tested (Blount et al., 2006) .
At medicinal levels (e.g. 800 mg), perchlorate competitively inhibits uptake of iodide by the sodium iodide symporter (NIS) in the thyroid gland (Tonacchera et al., 2004) . Iodide is the predominant form of iodine found in diet. Iodide anion accounts of > 90% of total iodine in urine and is the biologically available form that is transported into the thyroid to produce thyroid hormones. Since iodide is a key component of thyroid hormone, inhibiting its uptake into the thyroid can decrease thyroid hormone production. In the developing fetus and child, thyroid hormone is vital for proper development, and decreases in this hormone have been linked to significant decreases in IQ and other adverse neurologic outcomes (Haddow et al., 1999; Pop et al., 2003 Pop et al., , 1999 Henrichs et al., 2013) . Pregnancy is a time of thyroid stress and increased iodine demands, and this could lead to pregnancy being a period of particular susceptibility to perchlorate .
Thyroxine (T4) is the major circulating form of thyroid hormone, and free thyroxine (fT4) is its non-protein bound form. Thyroid stimulating hormone (TSH) is produced by the pituitary in response to low thyroid hormone concentrations in plasma, and stimulates the thyroid to produce more T4. Elevated TSH acts as a sensitive marker for thyroid stress since TSH is commonly effective at maintaining adequate serum concentrations of T4. In the largest study to date of perchlorate in pregnant women, we identified statistically significant associations between increasing urinary perchlorate concentrations and decreasing serum T4 and fT4 and increasing TSH concentrations (Steinmaus et al., 2015) . This study involved samples and data collected from pregnant women who gave birth in San Diego County between November 2000 and March 2003. This was a time when a large groundwater plume of perchlorate from a former perchlorate manufacturing plant contaminated the Las Vegas Wash, a tributary of the Colorado River (US EPA, 2005) . This contamination led to widespread perchlorate exposure, since the Colorado River supplies drinking water for 15-20 million people in Nevada, Arizona, and California, including much of San Diego County. The contamination resulted in perchlorate concentrations approaching the current California regulatory standard of 6 μg/L in the county's major drinking water supply. Other water sources in the county had much lower perchlorate concentrations. This exposure situation, combined with likely variations in intake of perchlorate from food, provided a wide range of perchlorate exposure among county residents.
Although several studies, including ours, have linked perchlorate to impacts on thyroid function, few studies have examined perchlorate in relation to overt adverse health effects. Based on the associations we identified in our previous study, and the well-known role thyroid hormone plays in fetal development, we investigated whether maternal perchlorate may have impacted birthweight or gestational age in our San Diego cohort. We also evaluated whether any associations we identified might be greater in certain potentially susceptible subpopulations. In previous research, perchlorate-thyroid hormone associations were greatest in subjects with elevated intakes of thiocyanate and nitrate, or with very high or low urinary levels of iodide (Blount et al., 2006; Steinmaus et al., 2015 Steinmaus et al., , 2007 . Thiocyanate (from foods or tobacco smoke) and nitrate (from foods or contaminated water) also competitively inhibit thyroid iodide uptake, and may have additive impacts with perchlorate (Tonacchera et al., 2004) . Previous research has also shown that birth outcomes or the adverse effects of environmental chemicals may be related to gender, ethnicity or race, or migration status (Heck et al., 2016 ; United Nations Development Programme, 2011), and we assessed potential susceptibility related to these factors as well.
Methods

Study design and data collection
Subjects were a convenience sample of pregnant women and their newborns from San Diego County, delivered from November 2000 to March 2003, and already recruited as part of Project Baby's Breath (PBB), a study of tobacco and other environmental exposures during pregnancy. PBB involved 14 hospitals and 41 community clinics and obstetrical care providers widely spread throughout the county, and the collection and frozen storage of urine, blood, and cord blood samples originally obtained for non-study purposes. Urine samples assayed for the present analysis were left over from spot urine samples collected from PBB subjects for pregnancy tests at a median of seven weeks gestation. After pregnancy testing, clinic staff transferred the remaining urine into 5 mL Corning cryovials that were refrigerated and transferred within one day to a central laboratory for storage at -20°C. Perchlorate is stable for many months in water at room temperature (Stetson et al., 2006) , and for years in frozen urine . Serum samples assayed for the present analysis were left over from samples collected by obstetrical care providers at approximately 15-20 weeks gestation from PBB subjects who participated in the California Prenatal Screening (PNS) Program (California Department of Public Health, 2010). After collection in 4 mL serum separator tubes, specimens were spun down and tested for chromosomal abnormalities and neural tube defects, with a median time between collection and PNS testing of three days. After PNS testing and 1-2 days of refrigeration, remaining serum from PBB study participants was transferred to 4 mL Corning cryovials and stored at -20°C. Samples not assayed within seven days of collection were excluded from the PNS and not available for PBB. Mannisto et al. reported that fT4 or TSH were relatively stable for 6 days at 4°C and up to 23 years at −25°C (Mannisto et al., 2007) . Information on mother's age, highest education, prenatal weight, payment method (e.g., private insurance vs. MediCal), and race/ethnicity was collected from birth records. Information on prenatal weight was derived from the PNS program. Gestational age was calculated using the date of conception estimated from ultrasound and information on last menstrual period collected during prenatal screening, a method that produces more accurate gestational age estimates than relying on last menstrual period dates from birth records (Dietz et al., 2007; Pearl et al., 2007) . For subjects not participating in prenatal screening (approximately 10%), gestational age was based on the date of last menstrual period recorded on birth records. Urine and serum samples, PNS program data, and birth records were linked using probabilistic matching software. PNS to birth match rates using this method are generally 93% (Kharrazi et al., 2012) . Informed consent was obtained for collection of leftover urine and blood specimens for the PBB study and for future testing of stored specimens for environmental contaminants. PNS program participants signed a consent/refusal form and received a privacy notification regarding research use of their specimen. The PBB study and the study presented here were approved by the State of California Committee for the Protection of Human Subjects.
Laboratory measurements
Urinary perchlorate is the most common biomarker for evaluating perchlorate exposure, since most ingested perchlorate is excreted unchanged in the urine . Urine samples were shipped overnight to the Centers for Disease Control and Prevention (CDC) on dry ice and analyzed by the CDC's Perchlorate Biomonitoring Laboratory for perchlorate (detection limit, 0.05 μg/L), thiocyanate (20 μg/L), nitrate (700 μg/L), and iodide (0.5 μg/L) using ion chromatography tandem mass spectrometry . Urinary cotinine levels were measured in 856 subjects by the CDC as part of a previous study. Results met the division's quality control criteria for accuracy and precision similar to those outlined in Caudill et al. Caudill et al. (2008) . After overnight shipping on dry ice, serum samples were measured for total T 4 , free thyroxine (fT 4 ), thyroid stimulating hormone (TSH)), and thyroperoxidase (TPO) and thyroglobulin (Tg) antibody concentrations at the University of Washington, Seattle, using a Beckman automated immunoassay chemiluminescence platform and microparticle enzyme immunoassay (Beckman Coulter). Quality control measures included 2-level quantitative controls for each assay on every reagent run, monitoring run integrity using Levey-Jennings charts, and participation in proficiency surveys by the College of American Pathologists. Manufacturers' values for TPO and Tg antibody positivity are > 9 and > 4 IU/mL, respectively.
Statistical analysis
This study initially included all pregnant women (n=2184) who participated in PBB and had a urine and/or blood sample with sufficient remaining specimen for laboratory analyses. Additional exclusion criteria for the analyses presented here included missing data on urinary perchlorate, thiocyanate, nitrate, iodide, or creatinine concentrations (n=139); missing data on birthweight or gestational age (n=32); multiple births (e.g. twins)(n=19); birth or pregnancy complications (e.g., hypertension, breech birth, diabetes)(n=30); or abnormally high maternal T4 (> 20 µg/dL) or TSH (> 10 µIU/mL) values (n=7).
Most statistical analyses were done using SAS version 9.1 (SAS Institute Inc.) and all reported p-values are two-sided. Univariate analyses of urinary analytes, serum thyroid hormones, birth outcomes, and sociodemographic variables were examined for distributions and outliers. Unadjusted analyses of perchlorate concentrations and birth outcomes by various sociodemographic characteristics were conducted using Wilcoxon rank sum tests, Spearman correlation coefficients, and Chi-square tests. Mean concentrations of perchlorate and the other urinary analytes in this study were compared to those calculated for reproductive-aged women (ages 15-45 years) from the 2001-2002 National Health and Nutrition Examination Survey using methods described elsewhere (Steinmaus et al., 2007) .
Associations between perchlorate and birthweight were examined using linear regression analyses in models both unadjusted and adjusted for urinary creatinine (log 10 ), maternal age (year), maternal weight (lbs), race (indicator variables for White, Black, Asian, Other), infant sex, maternal education (< high school, some high school, high school, beyond high school), Caesarean birth, medical insurance (private vs. MediCal), timing of urine sample collection (weeks gestation), ethnicity (Hispanic vs. non-Hispanic), and mother's birthplace (Mexico vs. US vs. other). When assessing subgroups based on race and ethnicity, we classified Hispanics as all subjects identifying as Hispanic regardless of race, and our other categories of race excluded Hispanics. Independent variables, including perchlorate, thiocyanate, nitrate, iodide, and creatinine were log 10 transformed to stabilize variance and reduce outlier influence. Variables that changed regression coefficients by more than 10% were retained in the final models and included creatinine, maternal age and weight, race, and sex. In addition to linear regression analyses, perchlorate-birthweight associations were evaluated by calculating mean birthweights by quartiles of perchlorate concentrations using proc GLM. Potential effect modification by factors such as infant sex, co-exposure to other NIS-related agents (nitrate, iodide, thiocyanate), and other factors (e.g. Caesarean birth, cotinine) was assessed by stratifying the linear regression analyses based on these factors or by entering interaction terms (e.g. perchlorate*thiocyanate) into the regression models. For nitrate, thiocyanate, and cotinine category cutoff points were based on tertiles. For urinary iodide we used categories of < 100, 100-300, and > 300 μg/L which correspond to median values used by the World Health Organization (WHO) to define iodine deficiency, normal values, and elevated iodine levels, respectively, in non-pregnant populations ≥6 years old (WHO, 2007) . A lower category cutoff of 150 μg/L, the WHO recommended population level for pregnant women, was assessed but produced similar results. Because previous studies have reported differences in birth outcomes by ethnicity or mother's migration status, stratified analyses were also done based on these factors (Markides and Coreil, 1986) .
Because the known toxic mechanism of perchlorate involves thyroid hormone and altered thyroid hormone levels have been linked to adverse birth outcomes (Krassas et al., 2010) , mediation by this pathway was assessed by comparing perchlorate-birthweight linear regression coefficients with and without adjustment for T4, fT4, or log 10 TSH levels and using the Sobel test and the SAS mediation macro provided by Valeri and VanderWeele (Valeri and Vanderweele, 2013) .
Logistic regression was used to calculate odds ratios for preterm birth (< 37 weeks gestation) across quartiles of urinary perchlorate concentration using the lower quartile as the reference. These models also included log 10 creatinine, maternal age and weight, race, and infant sex. The impact of adjusting for other factors such as iodide, Caesarean birth, mother's education, or sample collection timing was also assessed. Because the health implications of preterm birth can vary by birthweight (Yerushalmy, 1967) , and to explore possible impacts of perchlorate on birthweight and gestational age combined, we also calculated prevalence and ORs for various birthweight-gestational age strata (preterm birth below 2500 g, term birth below 2500 g, preterm birth 2500 g or above, and term birth 2500 g or above) using the categories similar to those proposed by Yerushalmy (Yerushalmy, 1967) . Here, all births not in the selected category were used as the reference group. The adjusted proportions of births in each category were assessed using the adjprop command in StataSE 14.0.
Results
Characteristics of the study population
Overall, 1957 mother-infant pairs met the inclusion criteria for this study. Distributions of perchlorate, thyroid hormones and other factors in the study population as a whole are shown in Table 1 . Urine perchlorate concentrations ranged from 0.23 to 177 µg/L, with a mean of 8.57 µg/L, which is higher than that seen in reproductive-aged US Abbreviations: fT4, free thyroxine; Max, maximum; Min, minimum; N, number of participants; SD, standard deviation; T4, total thyroxine; TSH, thyroid stimulating hormone. (Table A1 ). The median urinary iodide concentration was 153 µg/L, which is similar to the recommended population level for pregnant women of 150 µg/L (WHO, 2007) . The numbers of subjects, as well as mean perchlorate concentrations and birthweights, and the proportions of preterm births, in categories of various sociodemographic characteristics are shown in Table 2 . Overall, the study population was mostly Hispanic (69.1%), mostly used public medical insurance (69.9%), and mothers were mostly born in the US (45.1%) or Mexico (47.7%). Sociodemographic characteristics were similar in included and excluded subjects (Table A2 ). Mean perchlorate concentrations were higher in Blacks than Hispanics (11.85 vs. 8.42 µg/ L, p < 0.001), and lower in mothers born in Mexico and elsewhere compared to those born in the US (means of 8.40 (p=0.02), 7.63 (p=0.02), and 8.90 µg/L, respectively). Lower birthweights were associated with female sex (3341.4 vs. 3498.2 g, p < 0.001), decreasing maternal age (Spearman R=0.08, < 0.001), decreasing maternal weight (Spearman R=0.26, p < 0.001), and normal vaginal delivery (3400.5 vs. 3480.5 g, p < 0.001). Preterm births were somewhat higher in those with increasing maternal age (p-trend=0.06), and somewhat lower in mothers born in Mexico than in the US (7.5 vs. 8.8%, OR=0.84, 95% CI: 0.60-1.17).
Perchlorate-birthweight
In linear regression analyses, clear associations between log 10 perchlorate and birthweight were not seen when both sexes were combined (Table 3) . However, in analyses stratified by sex, an association was seen for male births (β=143.1 g increase for each 10-fold increase in perchlorate, p=0.01), but not for female births (β=−38.3 g, p=0.49). Given a median birthweight of 3498 g in male infants, the regression coefficient of 143.1 g identified here represents a 4.1% increase in birthweight for each 10-fold increase in urinary perchlorate concentration. In male infants, perchlorate-birthweight associations were greater in preterm births (β=829.1, p < 0.001) than in births ≥37 weeks gestation (β=97.3, p=0.06). Associations in male infants were also greater for those with US born mothers (β=297.2, p < 0.001) (Fig. 1) than those with Mexico-born mothers (β=29.9, p=0.68). In male births of US born mothers similar results were seen in categorical analyses where mean birthweights increased from the lowest to highest perchlorate quartile (3402.5, 3461.6, 3563.6, 3566 .8 g, respectively; ptrend=0.009) (Table A3 ). In US born mothers, results were similar in strata of Hispanics and Whites (data not shown). Adjusting for thiocyanate, iodide, nitrate, cotinine, education, Caesarean birth, Tg or TPO positivity, race, or insurance type had little impact on these birthweight results.
Analyses using interaction terms or stratified analyses showed no clear evidence of interaction with thiocyanate or nitrate on perchloratebirthweight associations in either sex (not shown). The perchloratebirthweight association was greater for male births with maternal iodide concentrations below 100 µg/L (β=177.3, p=0.05) and above 300 µg/L (β=301.1, p=0.06) compared to those with iodide concentrations between these levels (β=25.4, p=0.76) ( Table 3) .
Perchlorate-preterm birth
In both sexes combined, and in males and females separately, clear (Fig. A1) . Adjustments for thiocyanate, nitrate, iodide, cotinine, maternal weight or education, Tg or TPO positivity, or public vs. private insurance use, and removing the 191 subjects for whom gestational age was estimated based solely on birth certificate data, had little impact on perchlorate-preterm ORs. For preterm births < 2500 g, the OR in male infants comparing the upper to lower perchlorate quartiles was below 1.0 (OR=0.12, 95% CI: 0.02-0.61) although the number of births in this category was small (n=2 cases in the upper perchlorate quartile). This OR was close to 1.0 in females infants (OR=1.06; 95% CI: 0.28-3.97). Analyses stratified by mother's birthplace suggest the low OR in male infants for preterm birth < 2500 g primarily occurs in infants of US born mothers although sample sizes were very small (e.g. a total of 3 preterm births < 2500 g in the upper three perchlorate quartiles) (Fig. A1) . Fig. 2 displays the unadjusted proportions of all male births in several additional birthweight-gestational age categories, comparing subjects in the upper and lower perchlorate quartiles. As shown, there was a greater percentage of births in the preterm 2500-4000 g (9.9 vs. 3.8%) group and a lower percentage in the preterm < 2500 g (5.0% vs. 0.8%) group among subjects in the higher vs. lower perchlorate quartiles. Only small perchlorate-related differences were seen in the other birthweight-gestational age categories, including term > 4000 g babies. Adjustments for creatinine, maternal age and weight, and race had little impact on these results but led to non-robust results in categories with small numbers (not shown).
Thyroid hormone mediation
For the analyses of possible mediation of the perchlorate-birthweight association by thyroid hormone, 862 male births had data on maternal serum T4, fT4, and TSH concentrations. In these subjects, increasing log 10 perchlorate was associated with decreasing T4 (β=−0.73, p < 0.001) (Table A4) , decreasing fT4 (β=−0.043, p=0.05), and increasing log 10 TSH (β=0.069, p=0.03). Serum T4 was inversely associated with birthweight, when adjusting for log 10 perchlorate (β=−22.1 g, p=0.02) ( Table A4 ). The association between T4 and birthweight unadjusted for perchlorate and creatinine was −0.24 g (p=0.009). The log 10 perchlorate-birthweight linear regression coefficients unadjusted and adjusted for T4 were 149.8 (p=0.01) and 133.6 (p=0.03), respectively (Table A4) , giving a Sobel value ("indirect effect") of 16.2 (p=0.05) and suggesting a possible weak mediation effect. Further adjustments for maternal age, maternal weight, race, sex, or other factors had little impact on mediation results. The Sobel values for fT4 and log 10 TSH were near 4.0 and not statistically significant (not shown). No evidence of mediation by T4, fT4 or TSH was seen for the elevated odds ratios in male births for perchlorate and preterm births > 2500 g.
Discussion
We identified an association between increasing maternal urinary perchlorate concentrations and increasing birthweight in male infants. R. Rubin et al. Environmental Research 158 (2017) 72-81 Increasing perchlorate was associated with increases in the proportion of preterm births ≥2500 g in males and a corresponding decrease in the proportion of preterm births < 2500 g in males. These latter findings are consistent with our birthweight analysis in which the largest perchlorate-increased male birthweight associations were seen in the analyses confined to pre-term births. Overall, these results suggest that perchlorate may increase male infant birthweight, particularly in infants born preterm. An important strength of our study was the large size. With 1957 subjects this is the largest study of perchlorate in pregnant women to date. Another important feature was the unique contamination situation in the study area which is likely at least partially responsible for the wide range of perchlorate exposure seen in our study subjects. Wide contrasts in exposure like this increase the likelihood that true associations can be identified with good statistical power. Another strength was our access to data on a large number of variables including race and ethnicity; birth and pregnancy complications; socioeconomic factors like maternal education and insurance type; anti-thyroid antibodies; and related chemicals including cotinine, thiocyanate, nitrate, and iodine. These data allowed us to evaluate the potential confounding or modifying effects of a large number of factors that can potentially influence birth outcomes.
Only a few previous perchlorate studies have examined birth outcomes, and clear associations have not been seen (Blount et al., 2009; Evans et al., 2015; Tellez Tellez et al., 2005) . For example, in northern Chile, birthweights were similar in infants from cities with drinking water perchlorate concentrations of 113.9 µg/L (n=55 subjects), 5.82 µg/L (n=48), and below detection (n=55) although a large fraction of the subjects from the higher exposure city moved to and gave birth in the larger lower exposure city (Tellez Tellez et al., 2005) . In a recent study in New Jersey, maternal urinary perchlorate concentrations were not related to birthweight, although the sample size was small (n=107) and all subjects were recruited from a high risk pregnancy clinic (Evans et al., 2015) . The study presented here is the first report of perchlorate exposure potentially altering birthweight, and the first to examine perchlorate and preterm birth.
The mechanisms that underlie our results are unknown. However, given the well-established mechanism linking high doses (e.g. 500-800 mg/day) of perchlorate to decreased thyroid iodide uptake and decreased thyroid hormone production, and the well-known role of thyroid hormone in fetal development, pathways involving this hormone seem most likely (Leung et al., 2010) . Several studies have linked overt or subclinical hypothyroidism to increases in preterm birth, although findings are not consistent across all studies (Krassas et al., 2010) . Data linking thyroid function to changes in birthweight have also been inconsistent (Krassas et al., 2010) , although several results support the possibility that thyroid hormone could mediate our Table 4 Odds ratios for preterm birth by quartile of maternal urinary perchlorate concentration in the study population of pregnant women from San Diego County 2000-2003. findings. For example, in the FASTER Trial of 10,990 births from throughout the US, first trimester hypothyroxinemia was associated with birthweights > 4000 g (OR=1.97, 95% CI: 1.37-2.83) (ClearyGoldman et al., 2008) . In the Northern Finland Birth Cohort, clinical hypothyroidism (TSH > 95th percentile) was associated with a greater ponderal index (28.4 vs. 27.6 kg/m 3 , p < 0.05) and greater mean birthweight (3676 vs. 3568 g) although the later was not statistically significant (Mannisto et al., 2009) . In a study of all singleton births in Denmark from 1976 to 2006 (n=1,638,338) maternal hypothyroidism was associated with a 20 g (95% CI: 10-30 g) increase in birthweight and an odds ratio of 1.24 (95% CI: 1.17-1.31) for large-for-gestational age children (Andersen et al., 2013) . Other studies have not found clear associations between maternal hypothyroidism and birthweight (Casey et al., 2005; Finken et al., 2013) . Alterations in thyroid function have also been linked to gender-related effects on gonadal development, sex hormone and sex hormone binding globulin levels, and other outcomes (Krassas et al., 2010) , and it's possible one or more of these effects are related to the different results we identified in male versus female infants. As reported earlier, we found evidence that perchlorate decreases serum T4 and fT4 and increases serum TSH in the pregnant women in this cohort (Steinmaus et al., 2015) . In our analysis of mediation by T4 we also found evidence that decreasing serum T4 was associated with increasing birthweight (Table A3 ), highlighting the possibility that thyroid hormones could be mediating the perchlorate-birthweight associations we identified. Overall however, our mediation analyses suggested that T4 had only a weak mediating effect. Importantly though, this analysis was based on only a single assessment of thyroid hormone, levels of which change over the course of pregnancy and which have some day to day and within-day variability (Krassas et al., 2010) . In addition, pregnancy-related changes in serum proteins can impact the immunoassays we used to measure fT4 (Lee et al., 2009) . As a whole, these factors may have limited our ability to identify the true extent by which our results are mediated by thyroid hormones. The magnitude of the perchlorate-birthweight association we identified for male infants was greater when mothers had lower (< 100 μg/L) or higher (> 300 μg/L) urinary iodide concentrations (Table 3 ). For those with lower urinary iodide levels, this finding is consistent with the known mechanism of perchlorate (iodide uptake inhibition in the thyroid) and the potential impacts of thyroid hormone on birthweight discussed above. In most individuals, very high iodine intakes can transiently and paradoxically inhibit thyroid hormone production, termed the acute WolffChaikoff effect (Wolff and Chaikoff, 1948) . Typically, this is only temporary and thyroid function returns to normal after a few days, even if high iodine exposure continues (Eng et al., 1999) . However, several studies have reported increased rates of thyroid autoimmunity and hypothyroidism in areas where people have chronically high iodine intakes (Konno et al., 1994; Pedersen et al., 2007; Tajiri et al., 1986; Teng et al., 2006; Li et al., 1987) . This would suggest that chronic excessive high iodine intakes might lead to long-term hypothyroidism in some susceptible individuals. Although further research is needed on this issue, it may be that high iodine and perchlorate combine to reduce thyroid hormone production, and this combined exposure is responsible for the greater perchlorate-birthweight regression coefficient we saw in those with high urinary iodide levels.
The results of this study were also based on single assessments of urinary concentrations of perchlorate, iodide, thiocyanate, nitrate, and creatinine. All of these can also vary throughout the day and from day to day. The direction of any bias caused by this variability is unpredictable, however these variations would most likely reduce statistical power or bias any true associations to the null (Roy, 1994) . The half-life of perchlorate excretion is fairly short (e.g., 48-72 h) (Greer et al., 2002; Lamm et al., 1999; Selivanova and Arefaeva, 1986) . However, a study in New York City children following urinary perchlorate levels over a six-month period has shown that a single measurement can be used to accurately classify participants into low, medium, and high long-term exposure groups (Mervish et al., 2011) . Overall, although our metric of perchlorate exposure likely involved some misclassification, this was unlikely to have caused the positive results we identified.
Our analyses incorporated several potential confounding factors known to influence birth outcomes, including maternal age, race and ethnicity, adverse pregnancy or birth conditions, or indicators of low socioeconomic status (SES) like maternal education or insurance payment method. None of these appeared to cause major confounding in our study. We did not have information on some of the other factors that may influence birth outcomes, including certain genetic conditions, diet (including consumption of foods like dairy products that can be high in perchlorate), some medications, or the presence of treated thyroid disease. Some of these factors, including the use of most medications during pregnancy or genetic abnormalities are likely too rare to cause major confounding. Overall, although we did not see evidence of major confounding, residual confounding or unknown confounding by factors we did not assess cannot be completely excluded.
Several of our findings varied by mother's birthplace. The exact reasons for this are unknown, although some of this may be related to some of the same issues influencing the Hispanic paradox, the phenomenon that despite lower socioeconomic status, Hispanic mothers born in Mexico who migrate to the US may have better pregnancy outcomes than US-born mothers (DeCamp et al., 2015) . Although the exact causes of this have not been clearly delineated possible explanations could be greater family or community support, diet, lower rates of smoking or alcohol intake, or fewer birth or delivery complications. In our study, US-and Mexico-born mothers differed on several factors including urinary thiocyanate levels and public insurance use (data not shown), however none of these factors was found to be an important effect modifier in the perchlorate-birthweight associations we identified. Overall, given the small sample sizes in some analyses and the multiple comparisons we performed, chance cannot be ruled out as an explanation for these birthplace differences. As such any conclusions based on these particular findings are speculative and these analyses should be replicated in larger detailed studies before any firm conclusions regarding perchlorate and mother's birthplace can be made.
In conclusion, we found evidence of association between perchlorate and male infant birthweight, particularly in preterm births. The long-term consequences of these associations are unknown. A number of previous studies have identified associations between increased birthweight overall and adult obesity, a well-known risk factor for several chronic adult diseases (Schellong et al., 2012) , as well as overall increased morbidity and mortality (Van den Berg and Yerushalmy, 1966) . Whether or not these findings are directly relevant to our results is currently unknown. Regardless these previous studies highlight the importance and potentially adverse impacts of any factor that may alter birthweight or any other birth outcome. Given the novelty of our findings, the fact that some sample sizes are small in some analyses, and that confounding or other bias cannot be ruled out, further research is needed in other populations, and these findings should be considered preliminary. However, because perchlorate exposure is ubiquitous, and because it can potentially impact thyroid function and fetal development, further research on this agent could have widespread public health importance. a All models adjusted for urinary creatinine (log10). All models include the same 862 male subjects with information on perchlorate, creatinine, and maternal T4. b This model includes both log 10 perchlorate and serum T4. . 1. Lowest quartile of unadjusted maternal urinary perchlorate concentration (Q1) is used as the reference group. Odds ratios are for preterm birth compared to all other births (i.e. all term and post-term births). ORs are adjusted for creatinine (log10), maternal age, maternal weight, and race. 2. p-trend < 0.05. For US born mothers there were no cases of preterm births < 2500 g in third perchlorate quartile.
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